Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease Read more
OcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics programs Read more
Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB) Read more
StrideBio and Takeda Sign Collaboration and License Agreement to Advance Novel Gene Therapies for Neurological Diseases Read more
Imbrium Therapeutics Announces FDA Orphan Drug Designation for Tinostamustine for the Treatment of T-cell Prolymphocytic Leukemia Read more
Immuno-Oncology Company Elicio Therapeutics Launches with Novel Vaccine & Immunotherapy Platform to Treat an Array of Cancers Read more
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets Read more
Cook Regentec Launches ProFusion Therapeutic Infusion Needle for Intramuscular or Subdermal Infusion of Therapeutic Agents Read more